Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AMP vs Histamine for Bronchial Provocation in Asthma
NCT02318043Completed
- Sponsor
- Guangzhou Institute of Respiratory Health
- Start
- Jan 2007
- Primary completion
- Dec 2007
- Modality
- Small Molecules
01
Overview
Open-label trial of adenosine-5′-monophosphate in asthma (2 arms), sponsored by Guangzhou Institute of Respiratory Health. Primary endpoints: Cumulative dose eliciting 20% fall in FEV1 up to 12 months and Asthma symptom score as proposed by Hoggs et al up to 12 months. Started Jan 2007; status: completed.
02
Drugs
adenosine-5′-monophosphate
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02318043.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02318043.